← Ranking

MRVL · Marvell Technology, Inc.

Changes to watch · 1 concrete new risk (supply chain)

10-Q 2026-08-28 ↗ compared with the reference 10-K 10-K 2026-03-11 ↗

Closing price50-day average200-day average

Technical events and factor profile →

Summary

Marvell Technology warns of supply chain disruptions and AI risks. The company's dependence on Taiwan Semiconductor Manufacturing Company Limited for advanced process-node wafers is a significant concern.

Automatic summary generated from the filing; it may contain inaccuracies.
Concrete new risks
1
Generic new risks
0
Filing
10-Q · 2026-08-28

How the stock reacted

After the 10-Q1 session5 sessions20 sessions
MRVL-10.3%-13.5%+8.5%
Nasdaq-100 (QQQ)-0.6%-0.5%+3.4%
Difference-9.6%-13.0%+5.1%

From the close before the filing. Historical data, not a prediction.

What the concrete new risks are about

Supply chain · 1

New risks 1

Concrete fact Supply chain
Dependence on limited suppliers of critical materials

•risks related to our dependence on a limited number of suppliers of critical materials, including components, within our supply chain, and potential inability to obtain sufficient advance node wafers from Taiwan Semiconductor Manufacturing Company Limited (“TSMC”) as well as to obtain other critical components from other suppliers, to meet customer demand and our forecasts;

Key figures quarterly · USD

Revenue (TTM)
$9.5B
YoY growth
+36.5%
Operating margin
16.8%
Cash / debt
$3.9B / $5.0B
Aug 26May 26Jan 26Nov 25Aug 25
Revenue$2.7B$2.4B$2.2B$2.1B$2.0B
YoY growth+36.5%+27.6%+22.1%+36.8%+57.6%
Gross margin53.1%52.1%51.7%51.6%50.4%
Operating margin16.8%14.0%18.2%17.2%14.5%
Net income$308M$34M$396M$1.9B$195M
Diluted EPS0.330.040.452.200.22

XBRL data filed with the SEC. The fourth fiscal quarter is calculated as the full year minus the previous three quarters.

Factor profile percentile vs. the S&P 500 and the Nasdaq-100

Momentum
12 months excl. last: +171.2% · 6 months +63.1%
98
Trend quality
R² 0.25 · rising
65
Relative strength
+53.0% vs. the S&P 500 over 6 months
96
Volatility
76% annualised
96
Beta
beta 3.08
97
Distance from high
-28.0% from the 52-week high
21
Extension
-2.5 standard deviations from its 20-day average
3

0 = the lowest in the universe, 100 = the highest. It describes how the stock has behaved, not whether to buy or sell it. Screen stocks by factors

Management tone MD&A

+8

More optimistic than in the previous 10-Q (2026-05-28: +2, +6 points)

10-Q of 2026-08-28 · 25.0% positive sentences, 16.7% negative · 180 sentences analysed

Index from −100 to +100 calculated with FinBERT on the results discussion (MD&A). The change matters more than the level: some sectors always sound more cautious.

Top funds 13F

Soros Fund Management · George Soros
held since Q2 2026
0.3% $16.1M new
Bridgewater Associates · Ray Dalio
held since Q3 2023 or earlier
0.2% $54.0M -91%

Weight in each fund's portfolio and change vs. the previous quarter, from its latest 13F.

Recent material events (8-K)

2026-09-25 Other events 5 sessions: +3.2% vs Nasdaq-100 SEC ↗
2026-08-27 Results released 5 sessions: -13.0% vs Nasdaq-100 SEC ↗
2026-08-19 Material agreement signedUnregistered sale of shares 5 sessions: +12.2% vs Nasdaq-100 SEC ↗
2026-07-09 Other events 5 sessions: -20.2% vs Nasdaq-100 SEC ↗
2026-06-25 Shareholder voteOther events 5 sessions: -12.3% vs Nasdaq-100 SEC ↗
2026-06-11 Executive or board changesInvestor communication (Reg FD) 5 sessions: +7.4% vs Nasdaq-100 SEC ↗

All material events for MRVL →

Insiders · last 90 days

Buys
—
Discretionary sells
$301K
10b5-1 plan sells
$6.9M
2026-10-16 Bharathi Sandeep · President Sell (10b5-1 plan) $866K SEC ↗
2026-10-15 MURPHY MATTHEW J · CEO Sell (10b5-1 plan) $1.8M SEC ↗
2026-10-08 Scarpulla Justin · Officer Sell $301K SEC ↗
2026-10-01 Koopmans Chris · COO Sell (10b5-1 plan) $2.6M SEC ↗
2026-09-15 MURPHY MATTHEW J · CEO Sell (10b5-1 plan) $1.7M SEC ↗

Source: SEC EDGAR. Automatic comparison of the risk factors section; it may contain extraction errors. Always check the original document. For information purposes only; not investment advice.